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In response to an inflammatory stimulus, prior­
ities change with respect to the maintenance of 
tissue homeostasis. Under basal conditions, the 
microvascular endothelium has a low perme­
ability to plasma proteins and forms a barrier 
between high intravascular and low extravas­
cular interstitial fluid protein concentrations. 
This provides an oncotic gradient that balances 
the opposing hydrostatic pressure gradient that 
would otherwise move water and small solutes 
from the blood to the tissues, with any small net 
outflow being compensated by lymphatic drain­
age. After the detection of potentially harmful 
substances, foreign organisms, or injured tissue 
cells, the immediate priority is to supply plasma 
proteins to the extravascular compartment. This 
delivers immunoglobulins, constituents of the 
complement and coagulation systems, antipro­
teases, and other acute phase reactants to the 
site to participate in local host defense and the 
initiation of tissue repair. The compromise to 
homeostasis results in tissue edema (an example 
of functio laesa). Tissue mast cells act as sentinel 
cells and provide one means of detecting po­
tentially harmful agents by means of an array of 
receptors, including Toll­like receptors and IgE 
bound to FcR1. Mast cells release histamine 
that induces plasma leakage by acting directly 
on histamine receptors located on the venular 
endothelium, the region of the microvascu­
lature specialized for permeability responses 
(Majno and Palade, 1961). Increased permea­
bility is dependent on a destabilization of the 
VE­cadherin–catenin complex and its inter­
action with the actin cytoskeleton at EC junc­
tions (Yuan, 2002; Schulte et al., 2011). Other 
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Microvascular plasma protein leakage is an essential component of the inflammatory 
response and serves an important function in local host defense and tissue repair. Media-
tors such as histamine and bradykinin act directly on venules to increase the permeability 
of endothelial cell (EC) junctions. Neutrophil chemoattractants also induce leakage, a 
response that is dependent on neutrophil adhesion to ECs, but the underlying mechanism 
has proved elusive. Through application of confocal intravital microscopy to the mouse 
cremaster muscle, we show that neutrophils responding to chemoattractants release TNF 
when in close proximity of EC junctions. In vitro, neutrophils adherent to ICAM-1 or ICAM-2 
rapidly released TNF in response to LTB4, C5a, and KC. Further, in TNFR/ mice, neutro-
phils accumulated normally in response to chemoattractants administered to the cremaster 
muscle or dorsal skin, but neutrophil-dependent plasma protein leakage was abolished. 
Similar results were obtained in chimeric mice deficient in leukocyte TNF. A locally injected 
TNF blocking antibody was also able to inhibit neutrophil-dependent plasma leakage, but 
had no effect on the response induced by bradykinin. The results suggest that TNF mediates 
neutrophil-dependent microvascular leakage. This mechanism may contribute to the effects 
of TNF inhibitors in inflammatory diseases and indicates possible applications in life-
threatening acute edema.
© 2014 Finsterbusch This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
Abbreviations used: SMA,  
-smooth muscle actin; BM, 
basement membrane; EC, 
endothelial cells; HBP, heparin-
binding protein; LTB4, leukotriene 
B4; PECAM, platelet endothelial 
cell adhesion molecule; ROI, 
region of interest; TEM, 
transendothelial cell migration; 
VEGF, vascular endothelial cell 
growth factor.
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chemoattractant­induced increased microvascular permea­
bility and describe a potential mechanism for neutrophil­ 
dependent edema.
RESULTS AND DISCUSSION
Neutrophil chemoattractants induce  
generation of TNF in vivo
As part of our investigations into the impact of proinflam­
matory mediators on venular morphology in vivo (Voisin 
et al., 2010; Proebstl et al., 2012), we noted that locally ad­
ministered neutrophil chemoattractants can induce pericyte 
shape change in mouse cremaster postcapillary venules in a 
TNF­dependent manner (Fig. 1, A and B). Specifically, intra­
scrotal administration of the chemoattractants LTB4, C5a, 
and KC (CXCL1) caused pericyte shape change in WT mice, 
as indicated by an increase in gaps between adjacent pericytes. 
These effects were totally absent in TNFR/ mice (Fig. 1 B), 
suggesting that chemoattractants can induce the generation 
of endogenous TNF in close proximity to venular walls. As 
expected, the response to exogenous TNF was also abolished 
in the TNFR/ mice (Fig. 1 B). LTB4, C5a, and KC did not 
induce pericyte shape change in neutrophil­depleted mice 
(Fig. 1 C), indicating that the generated TNF was derived 
from neutrophils.
TNF is associated with neutrophils adherent  
to venular ECs in LTB4-stimulated tissues in vivo
To gain a better understanding of the functional role of 
endogenously generated TNF, we sought to investigate the 
site and dynamics of TNF release in response to neutrophil 
chemotactic mediators in vivo. Initial in vitro studies pro­
vided direct evidence for the existence of preformed intracel­
lular TNF stores in mouse blood neutrophils and the ability of 
these cells to rapidly release TNF in response to LTB4 (Fig. 2, 
A and D). This was shown by the time­dependent loss of 
intracellular TNF in neutrophils stimulated with LTB4 (Fig. 2, 
A, B, and D) and by the detection of soluble TNF in super­
natants of these cells (Fig. 2 C). To investigate the dynamics 
of TNF release from neutrophils within microvessels of 
chemoattractant­stimulated tissues in vivo, a protocol was 
developed for detecting expression of TNF during early 
neutrophil­venular wall interactions. Cremaster muscles of 
Lys-EGFP-ki mice were examined by confocal intravital 
microscopy as previously detailed (Woodfin et al., 2011). Fur­
thermore, in vivo immunostaining of EC junctions using an 
anti–PECAM­1 mAb allowed tracking of GFPhigh neutrophil 
responses within the venular lumen, neutrophil transendo­
thelial cell migration (TEM), and neutrophil sub­EC migra­
tion (Woodfin et al., 2011; Proebstl et al., 2012). This previously 
established protocol was extended to enable us to simultane­
ously visualize the localization of TNF as detected by an i.v. 
injected fluorescently labeled anti­TNF mAb. Using this ap­
proach, no TNF was detected during the early steps of neu­
trophil adhesion and crawling along the luminal side of ECs 
after topical LTB4 application (Fig. 2, E and F). However, TNF 
could be detected on the surface of neutrophils a few minutes 
such mediators acting directly on ECs include bradykinin, 
peptidoleukotrienes, platelet­activating factor, and VEGF.
Inflammatory stimuli also trigger the local production of 
chemoattractants that induce acute neutrophil infiltration. 
Once accumulated and interacting with the potentially inju­
rious stimulus, these cells were generally accepted to con­
tribute to tissue swelling in the later stages of inflammation 
by releasing substances that damage the endothelium, such as 
proteases and reactive oxygen species. Subsequent observa­
tions suggested another link between neutrophils and increased 
microvascular permeability by a mechanism that could oper­
ate in the very early stages of the inflammatory response. The 
neutrophil chemoattractants C5a, leukotriene B4 (LTB4), and 
fMLP were found to induce significantly increased EC per­
meability within 6 min of injection into animal skin, and 
these responses were absent in animals depleted of their cir­
culating neutrophils (Wedmore and Williams, 1981). This led 
to the conclusion that neutrophils responding to a chemo­
attractant signal can rapidly increase the permeability of EC 
junctions when the leukocytes are in close apposition to ven­
ular ECs; thus, regulating the supply of plasma proteins to the 
extravascular space. This concept was supported by studies 
in which a blocking anti­2 integrin mAb was found to inhibit 
neutrophil­dependent edema (Arfors et al., 1987). Collectively, 
neutrophil chemoattractants, including chemokines, have been 
found to increase microvascular permeability in several animal 
species (Wedmore and Williams, 1981; Williams and Jose, 
1981; Björk et al., 1982; Tokita and Yamamoto, 2004), and 
responses to intradermal C5a have been shown to be mark­
edly reduced in neutropenic human subjects (Williamson et al., 
1986; Yancey et al., 1987).
The perivascular basement membrane (BM) is permeable 
to plasma proteins and allows their entry into tissues when 
EC junctions open. Large colloidal molecules administered 
into the systemic circulation are, however, trapped under the 
BM/pericyte layer, which is the basis of the vascular labeling 
technique that first identified venules as the site of action 
of histamine (Majno and Palade, 1961). Some early studies 
showed that neutrophils can disrupt the perivascular BM so 
that large colloidal molecules can pass through (Hurley, 1964; 
Huber and Weiss, 1989). These observations may relate to 
our previous findings that show changes in BM morphology 
and enlarged gaps between pericytes induced by inflamma­
tory mediators in vivo (Wang et al., 2006; Voisin et al., 2009; 
Proebstl et al., 2012). In extending these findings, we noted 
that neutrophil chemoattractants induced pericyte shape 
change in vivo in a neutrophil­dependent manner, and that 
this response was mediated by endogenously generated TNF. 
Because, in response to chemoattractants, neutrophils within 
the vascular lumen expressed TNF in close proximity of 
EC junctions and TNF increases microvascular permeabil­
ity to plasma proteins (Brett et al., 1989), we investigated 
if neutrophil­derived TNF could also provide an important 
link between neutrophils and increased endothelial perme­
ability. The present results provide direct evidence for the 
ability of endogenous neutrophil­derived TNF to mediate 
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adherent neutrophils corresponded to 43–88% of the total 
intracellular level of TNF. Collectively, these results demon­
strate that EC 2 integrin ligands can positively regulate TNF 
release from neutrophils although the extent of this priming 
effect is stimulus­specific.
Endogenous TNF mediates neutrophil-dependent  
increased microvascular permeability in vivo
As TNF expression was associated with neutrophil­venular wall 
interactions, we postulated that the release of this cytokine may 
change the barrier function of the EC monolayer. Locally ad­
ministered neutrophil chemoattractants induced neutrophil 
infiltration into the cremaster muscle in WT mice, which 
were not significantly different in TNFR/ mice (Fig. 4 A). 
These results indicate that endogenous TNF does not play a key 
role in mediating acute neutrophil infiltration induced by neu­
trophil chemoattractants in this model. However, vascular leak­
age induced by LTB4 in the cremaster muscle, quantified as the 
local accumulation of i.v. injected Evans Blue, was abolished in 
TNFR/ mice (Fig. 4 B). This phenomenon was also investi­
gated in the mouse dorsal skin, where depletion of circulating 
neutrophils blocked microvascular leakage induced by LTB4, 
but had no effect on the response to exogenous TNF (Fig. 4 C). 
In the dorsal skin, LTB4, C5a, and KC were all found to induce 
rapid and transiently increased microvascular permeability, with 
the greatest plasma protein leakage being noted within the first 
30 min after injection (Fig. 4 D). As observed using LTB4 in the 
cremaster muscle, microvascular leakage induced by all of these 
stimuli was inhibited in the dorsal skin of TNFR/ mice 
(Fig. 4 E), and chimeric mice generated by bone marrow 
transfer of TNF/ hematopoietic stem cells into WT recipients 
(Fig. 4 F). The latter results specifically indicate the importance 
before TEM, a response that was sustained during the breach­
ing of the endothelium and remained elevated during neu­
trophil sub­EC crawling for observation periods of up to 
45 min (Fig. 2, E and F). No such increase in signal was de­
tected in mice injected with a control mAb. Collectively, these 
results provide direct evidence for the ability of LTB4 to stim­
ulate a rapid release of TNF from neutrophils in vitro and in vivo. 
In vivo, this response occurred when neutrophils were in close 
association with the venular wall, suggesting that neutrophil–
EC interactions facilitate TNF release/cell surface expression 
and that endogenously generated TNF may regulate early neu­
trophil­dependent microvascular responses. These key issues 
were addressed in the studies detailed below.
Neutrophils in suspension, or adherent to ICAM-1 or ICAM-2, 
can rapidly release TNF in response to chemoattractants
Previous studies have indicated the importance of 2 integrin­ 
mediated neutrophil­EC adhesion in neutrophil­dependent 
increased microvascular permeability (Arfors et al., 1987; 
Gautam et al., 2000). To investigate the impact of this pathway on 
TNF release, purified neutrophils in suspension or adher­
ent to ICAM­1 or ICAM­2 (key EC 2 integrin ligands), 
were stimulated with LTB4, C5a, or KC, and supernatants 
were assayed for TNF. LTB4 was clearly able to stimulate TNF 
release from neutrophils in vitro and engagement of ICAM­1 
or ICAM­2 was not a prerequisite for secretion under the 
conditions of these experiments, although there was a trend 
toward enhanced and/or accelerated TNF release from neu­
trophils adherent to ICAMs (Fig. 3 A). In contrast to LTB4, 
the stimuli KC and C5a induced significant levels of TNF 
release from neutrophils only when the cells were adherent to 
ICAM­1 or ICAM­2 (Fig. 3 B). TNF secreted from stimulated 
Figure 1. TNF mediates chemoattractant-
induced changes in venular morphology. 
(A) Representative confocal images of post-
capillary venules from five independently 
conducted control (PBS) or chemoattractant-
stimulated cremaster muscles (4 h) labeled for 
pericytes (SMA). Bar, 20 µm. (B) Pericyte gap 
size was quantified in cremasteric postcapillary 
venules of WT and TNFR/ mice injected with 
PBS (n = 10 and 5, respectively), LTB4 (n = 12 
and 4, respectively), C5a (n = 5 and 4, respec-
tively), KC (n = 5 and 4, respectively), or TNF 
(n = 4 and 3, respectively) for 2-4 h, involving 
12 independent experiments. (C) As above but 
using control mice (n = 3 for PBS and LTB4, 
n = 5 for C5a, n = 6 for KC) or mice depleted 
of their circulating neutrophils (n = 3 mice/
group), involving 5 independent experiments. 
Six vessel segments per mouse were analyzed. 
Data are means ± SEM. Significant differences 
from PBS-treated tissues or other statistical 
comparisons (indicated by lines) are shown by 
asterisks. ***, P < 0.001.
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of neutrophil­derived TNF in chemoattractant­induced mi­
crovascular leakage. Exogenous TNF was an effective inducer 
of increased microvascular permeability in the skin, a response 
that was undetectable in TNFR/ mice, but as expected, was 
normal in the chimeric mice (Figs. 4, E and F). In line with our 
overall hypothesis that TNF mediates neutrophil­dependent 
increased microvascular permeability, exogenous TNF induced 
rapid plasma protein leakage. Specifically, the bulk of the re­
sponse occurred within the first 30 min (Fig. 4 G) and signifi­
cant vascular leakage was detected as early as 15 min after local 
administration of TNF (Fig. 4 H). A blocking anti­TNF mAb, 
when co­injected with LTB4, also inhibited increased microvas­
cular permeability, but this protocol had no impact on vascular 
leakage induced by the neutrophil­independent permeability­
increasing mediator bradykinin (Fig. 4 I).
A model for neutrophil-dependent edema
In summary, we provide evidence for the involvement of 
endogenously generated TNF as a mediator of neutrophil­
dependent increased microvascular permeability. Several 
permeability­increasing substances have been proposed as 
mediators of this process, including TNF (DiStasi and Ley, 
2009), but direct evidence for a conclusive mechanism has 
been lacking. We propose the following sequence of events 
within the context of an acute inflammatory response. Chemo­
attractants generated in tissues in response to an inflamma­
tory stimulus engage with their receptors on neutrophils 
within the venular lumen and trigger 2­integrin activation. 
This induces rapid neutrophil adhesion, crawling on the ven­
ular wall, and the initiation of TEM mediated by the 2 inte­
grin EC ligands ICAM­1 and ICAM­2 (Phillipson et al., 2006; 
Ley et al., 2007; Woodfin et al., 2009; Halai et al., 2014). When 
Figure 2. Chemoattractants stimulate release of TNF from neutro-
phils in vitro and in vivo. Mixed mouse blood leukocytes were treated 
with PBS (control) or stimulated with LTB4 (10 or 30 min). Supernatants 
were assayed for soluble TNF by ELISA and cells were permeabilized and 
immunostained for analysis of intracellular TNF by flow cytometry and 
confocal microscopy. (A) Representative flow cytometry histograms from 
4 independent experiments showing the binding of anti-TNF mAb (black 
lines) or control IgG (filled). (B) Quantification of intracellular TNF by flow 
cytometry (expressed as RFI; n = 6 blood samples for PBS and 30 min 
LTB4, n = 5 for 10 min LTB4) from 4 independent experiments. (C) Quanti-
fication of released TNF (n = 4) from 4 independent experiments. ND, not 
detected. (D) Representative confocal images of neutrophils from two 
independent experiments show cells treated with PBS or LTB4 (10 and  
30 min) and stained for the neutrophil marker MRP-14 (green) or TNF (red). 
Bar, 5 µm. (E) Representative 3D-reconstructed images of LTB4-stimulated 
cremasteric postcapillary venule (luminal side) showing GFP-neutrophils 
and PECAM-1–labeled ECs (red). The top panel shows neutrophils at dif-
ferent steps of the transmigration response, i.e., luminal crawling, preTEM 
phase (6 min before breaching ECs), TEM phase, and abluminal crawling. 
The associated TNF detected on the leukocyte surface for each step (in-
tensity rainbow color code from blue [low intensity] to red [high inten-
sity]) is shown in the bottom panels with and without the associated 
neutrophil. Bar, 5 µm. (F) Mean fluorescent intensity of signals on neutro-
phils was quantified in mice injected with anti-TNF or control mAbs (n = 4 
mice/group) from 4 independent experiments. A total of 40 neutrophils 
were tracked and analyzed for each group. All data are means ± SEM. 
Statistical differences from PBS (B and C), signals from luminal crawling 
cells (F), or other comparisons (indicated by lines) are shown by asterisks. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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of anionic TNF on the venular endothelium, with both ef­
fects potentially contributing to a synergism between HBP 
and TNF.
As the perivascular BM is regarded as freely permeable 
to plasma proteins, the remodeling of the BM and the con­
comitant increases in gaps between adjacent pericytes that we 
observed (the starting point in this study) may have little ef­
fect on the rate of passage of plasma proteins into the tissues. 
Such changes in pericyte and BM morphology may be more 
relevant to the extravasation of blood­borne cells, micro­
organisms, or high molecular weight immune complexes under 
certain circumstances.
These observations provide an explanation for the rapid 
neutrophil­dependent microvascular plasma protein leakage 
induced by neutrophil chemoattractants in vivo (Wedmore 
and Williams, 1981) and its inhibition by an anti­2 integrin 
mAb (Arfors et al., 1987). As in the mouse, human neutro­
phils are also able to secrete TNF (Smedman et al., 2009). Thus, 
therapeutic TNF inhibitors may owe part of their efficacy in 
chronic inflammatory diseases to the mechanisms postulated 
here. Further, the use of TNF inhibitors might be considered, 
or revisited, for other conditions, particularly those where 
acute microvascular leakage is a life­threatening component.
MATERIALS AND METHODS
Mice. TNF receptors p55 and p75 double knockout mice (TNFR/) on a 
C57BL/6 background were from The Jackson Laboratory and C57BL/6 
WT mice from Harlan–Olac were used as controls. Lys­EGFP­ki mice 
(backcrossed to C57BL/6 for at least eight generations), exhibiting EGFPhigh 
fluorescent neutrophils (Faust et al., 2000), were used with the permission of 
T. Graf (Albert Einstein College of Medicine, Bronx, NY) and were pro­
vided by M. Sperandio (Ludwig Maximilians University, Munich, Germany). 
Chimeric mice deficient in leukocyte TNF were generated by lethal irradia­
tion of C57BL/6 WT mice (5.5 Gy twice, 4 h apart) and injection of bone 
marrow cells (1.5 × 106 cells/recipient i.v.) from TNF/ mice (gift from 
V. Quesniaux, Centre National de la Recherche Scientifique Orleans, France). 
C57BL/6 WT littermates receiving WT bone marrow were used as con­
trols. Mice were used between 6–12 wk of age. All animal experiments were 
conducted according to The Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 (SI 2012/3039), all projects are reviewed and 
approved by the Animal Welfare and Ethical Review Board (AWERB) 
within Queen Mary University of London.
the neutrophils are undergoing TEM or are located on the 
abluminal surface of ECs, chemoattractants induce the rapid 
surface expression and release of preformed TNF from the 
leukocytes, a response that can be up­regulated by adhesive 
interactions with ECs. The binding of TNF to its receptors 
on ECs stimulates the phosphorylation and endocytosis of the 
VE­cadherin complex in the junctions (Schulte et al., 2011) 
together with actomyosin contraction (Yuan, 2002), resulting 
in the opening of EC junctions and the leakage of plasma 
proteins. The signaling pathways that mediate TNF­induced 
increased EC permeability have been extensively studied and 
appear to involve activation of the small GTPase Rac (Cain 
et al., 2010) and the phosphatidylinositol (3,4,5)­trisphosphate–
dependent Rac exchanger 1 (P­Rex1; Naikawadi et al., 2012).
As TNF is both secreted from neutrophils and is a neutro­
phil secretagogue, it is potentially possible that under some 
inflammatory conditions TNF may act cooperatively with 
other neutrophil­derived EC permeability factors. Of im­
portance, we have found that neutrophil­dependent micro­
vascular leakage is unaffected in neutrophil elastase/ mice 
and in animals treated with ROS inhibitors (unpublished 
data). However, other factors may act synergistically with 
TNF, e.g., neutrophil­derived heparin­binding protein (HBP; 
CAP37, azurocidin), which has been implicated in neutrophil­
dependent plasma leakage (Gautam et al., 2001; Di Gennaro 
et al., 2009). High concentrations of recombinant HBP have 
been shown to increase endothelial permeability, a charge­
dependent effect (Gautam et al., 2001) similar to that of other 
very basic molecules such as polylysine (Needham et al., 
1988). Supernatants from LTB4­stimulated neutrophils have 
been reported to increase endothelial permeability, a response 
lost after incubation of supernatants with a solid phase poly­
clonal antibody to HBP (Di Gennaro et al., 2009). However, 
based on our observations, such supernatants would be ex­
pected to contain TNF, which may be removed by the anti­
body as a consequence of ionic interactions between highly 
positively charged HBP and the negatively charged cytokine. 
At lower concentrations, HBP is able to augment neutrophil 
adhesion (Lee et al., 2003) and may facilitate the retention 
Figure 3. Neutrophils in suspension or 
adherent to ICAM-1 and ICAM-2 release 
TNF in response to chemoattractants. Pu-
rified neutrophils in suspension or after adhe-
sion to ICAM-1– or ICAM-2–coated plates 
were stimulated with LTB4 for 15 (n = 5, 7, 
and 7 samples, respectively) or 30 min (n = 4, 
6, and 6 samples, respectively; A) or KC and 
C5a (n = 3) for 30 min (B). Control samples (in 
suspension or adherent to ICAM-1 o ICAM-2) 
were treated with PBS (n = 6, 7, and 7, re-
spectively). Supernatants were assayed for 
TNF by ELISA. Graphs show means ± SEM of  
3 independent experiments. ND, not detected. 
Significant differences from PBS control are 
indicated by asterisks. *, P < 0.05; **, P < 0.01; 
***, P < 0.001.
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captured using a LSM 5 PASCAL confocal laser­scanning microscope (Carl 
Zeiss) incorporating a 40× water­dipping objective (numerical aperture 0.8, 
resolution 0.37 µm). Z­stack images of half postcapillary venules (20–45 µm 
diam) were captured using the multiple track scanning mode at a resolution of 
800 × 800 pixels in the x × y plane. The size (area) of gaps between adjacent 
pericytes and the number of transmigrated neutrophils were analyzed in 
postcapillary venules using ImageJ (National Institutes of Health) or IMARIS 
(Bitplane), respectively, as described previously (Wang et al., 2006; Voisin et al., 
2010). In brief, 3D­reconstructed confocal images of half vessels (vessels were 
split along the longitudinal axis) were artificially displayed on a 2D surface 
(z­projection, maximum intensity) and converted into 8­bit grayscale projec­
tions. Gaps between adjacent pericytes (SMA­negative regions) were either 
manually encircled across 200­µm vessel segments, or automatically quantified by 
ImageJ. The values of all ROI areas/vessel segment were cumulated and an aver­
age unit area of at least 4 vessel segments per mouse were quantified and plotted 
Induction of cremasteric inflammatory reactions and ex vivo analysis 
of tissues by confocal microscopy. Male mice were anaesthetized by i.m. 
injection of 1 ml/kg ketamine (40 mg)/xylazine (2 mg) in saline. LTB4 (30 ng; 
Merck), C5a (300 ng; R&D Systems), KC (500 ng; AbD Serotec), or TNF 
(300 ng; R&D Systems) in 300 µl PBS or PBS alone were administered intra­
scrotally. Reaction times were as indicated, i.e., 2 h (KC and TNF) or 4 h 
(LTB4, C5a, and IL­1). At the end of each in vivo test period, mice were 
sacrificed and cremaster muscles were prepared for immunofluorescence 
staining and subsequent ex vivo analysis as previously described (Wang et al., 
2006). In brief, cremaster muscles were fixed in 4% paraformaldehyde at 4°C, 
blocked and permeabilized in 10% normal goat serum, 10% FCS, and 0.5% 
Triton X­100 at room temperature. To visualize pericytes and neutrophils, 
tissues were incubated with primary antibodies anti–SMA­Cy3 (1A4; Sigma­
Aldrich) and anti–MRP­14 (gift from N. Hogg, Cancer Research UK, Lon­
don, England) conjugated to Alexa Fluor 647. 3D confocal images were 
Figure 4. TNF mediates chemoattractant-induced microvascular leakage. (A) Neutrophil transmigration was quantified in cremasteric postcapil-
lary venules of WT and TNFR/ mice injected with PBS (n = 11 and 5 mice, respectively), LTB4 (n = 25 and 4, respectively), C5a (n = 8 and 4, respectively), 
KC (n = 5 and 4, respectively), or TNF (n = 4 and 3, respectively) for 2-4 h involving 23 independent experiments. (B) Vascular leakage was analyzed in the 
cremaster muscle of WT and TNFR/ mice treated with PBS (n = 4 and 3 mice, respectively) or LTB4 (4 h; n = 4 and 3 mice, respectively) from 4 indepen-
dent experiments. (C) Vascular leakage in the dorsal skin of WT or neutrophil-depleted mice after i.d. injection of PBS (n = 9 and 8 mice, respectively), LTB4 
(n = 3 mice), or TNF (n = 6 and 5 mice, respectively; 4h) from 3 independent experiments. (D) Kinetics of vascular leakage in the dorsal skin of WT mice 
injected i.d. with PBS (n = 9), LTB4 (n = 3), C5a (n = 3), or KC (n = 3) from 3 independent experiments. (E) Vascular leakage in the dorsal skin of WT or 
TNFR/ mice injected i.d. with PBS (n = 9 mice/group), or the indicated stimuli (30 min; n = 3 mice/group) from 3 independent experiments. (F) Vascular 
leakage in the dorsal skin of TNF/ chimeric mice or control mice injected i.d. with PBS or the indicated stimuli (30 min; n = 8 mice/group) from 3 inde-
pendent experiments. (G) Kinetics of vascular leakage in the dorsal skin of WT mice injected i.d. with PBS (n = 9) or TNF (n = 3) from 3 independent ex-
periments. (H) Time course of vascular leakage in the dorsal skin of WT mice injected i.d. with PBS or TNF (n = 4 mice/group) from 3 independent 
experiments. (I) Vascular leakage in the dorsal skin of WT mice was analyzed after i.d. injection of PBS, LTB4, or BK when co-injected with a control mAb  
(n = 10) or an anti-TNF blocking mAb (n = 8) using a 30 min reaction time from 3 independent experiments. All datasets are means ± SEM. Statistically  
significant differences from PBS treatment or other comparisons (indicated by lines) are shown by asterisks. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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at 56°C for 24 h. The amount of accumulated Evans blue in the tissue super­
natant was quantified by spectroscopy at 620 nm.
Isolation and adhesion assay of blood neutrophils. Murine blood 
neutrophils were isolated using an anti–Ly­6G MicroBead kit (MACS; Miltenyi 
Biotec) according to the manufacturer’s protocol (93% neutrophil purity 
was obtained as determined by flow cytometry). Cells, pooled from 4–6 mice 
(2 × 105 cells in 100 µl RPMI containing 10% FCS and 25 mM HEPES), 
were seeded onto 16­well Laboratory­Tek glass chamber slides (Thermo 
Fisher Scientific) precoated with rhICAM­1 (2.5 µg/ml) or rmICAM­2 
(10 µg/ml; both from R&D Systems) and allowed to adhere for 30 min at 
37°C before being stimulated with LTB4 (10 nM), KC (3 nM), or C5a 
(3 nM). Control cells received PBS only. For comparison, purified neutro­
phils kept in suspension in LoBind tubes (Eppendorf) were also stimulated 
with chemoattractants or PBS. Supernatants were taken after 15 or 30 min 
stimulation and assayed for TNF by ELISA (eBioscience; sensitivity of 8 pg/ml). 
Total neutrophil intracellular content of TNF was quantified as 25 pg/ml 
as measured in cell lysates of samples containing 2 × 106 neutrophils/ml. Ad­
hesion to slides was quantified by DAPI staining and IMARIS analysis.
Stimulation and analysis of blood leukocytes by flow cytometry and 
confocal microscopy. Whole blood was collected from WT mice and 
red blood cells were lysed with AKC lysis buffer (150 mM NH4Cl, 1 mM 
KHCO3, and 0.1 mM EDTA). Mixed blood leukocytes, pooled from 2–3 
mice (2 × 106 cells in 1 ml) were stimulated with 10 nM LTB4 in PBS com­
plemented with 0.25% FCS, 1 mM CaCl, 1 mM MgCl, and 5 mM glucose 
for 10 or 30 min at 37°C. Supernatants were recovered for ELISA and stored 
at 80°C. Cells were washed twice at 500 g for 10 min at 4°C and analyzed 
by flow cytometry or confocal microscopy. For flow cytometry cells were 
co­stained for different leukocyte surface markers using the following anti­
bodies: anti–Ly6G­PE (1A8; BioLegend; neutrophils), anti–CD115­A488 
(AFS98; eBioscience; monocytes), anti–CD45­PE/Cy5 (RA3­6B2; Bio­
Legend; pan­leukocyte marker), and anti–CD3e­PE­Cy5 (145­2C11; eBiosci­
ence; T cells). For intracellular cytokine detection and MRP­14 labeling (for 
confocal microscopy only), cells were fixed and permeabilized using BD Cy­
tofix/Cytoperm Kit (BD), and stained with an anti­TNF Ab (MP6­XT22), 
or isotype­matched control Ab (conjugated to Alexa Fluor 647 or 555, re­
spectively), or anti­MRP14 Ab conjugated to Alexa Fluor 488. For confocal 
microscopy cells were further stained with the nuclear dye DRAQ5. Surface 
and intracellular expression of molecules of interest were measured by flow 
cytometry on a FACSFortessa (BD) and analyzed using FlowJo software 
(Tree Star) (neutrophils were gated as Ly6G+ CD45+ CD115 CD3 cells) 
or a LSM 5 PASCAL confocal laser­scanning microscope (Carl Zeiss) incor­
porating a 63× oil­dipping objective (NA 1.4) analyzed with IMARIS.
Statistical analyses. Data are presented as means ± SEM of at least 3 inde­
pendent experiments. Statistical differences between groups were analyzed 
using Student’s t test or ANOVA followed by Dunnett or Bonferroni multiple 
comparison tests. P values <0.05 were considered significant.
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